Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.
Please read the tutorial at this link: https://ebookbell.com/faq
We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.
For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.
EbookBell Team
0.0
0 reviewsHuman diseases are characterized by intricate cellular dynamics. Single-cell transcriptomics provides critical insights, yet a persistent gap remains in computational tools for detailed disease progression analysis and targeted in silico drug interventions. Here we introduce UNAGI, a deep generative neural network tailored to analyse time-series single-cell transcriptomic data. This tool captures the complex cellular dynamics underlying disease progression, enhancing drug perturbation modelling and screening. When applied to a dataset from patients with idiopathic pulmonary fbrosis, UNAGI learns disease-informed cell embeddings that sharpen our understanding of disease progression, leading to the identifcation of potential therapeutic drug candidates. Validation using proteomics reveals the accuracy of UNAGI’s cellular dynamics analysis, and the use of the fbrotic cocktail-treated human precision-cut lung slices confrms UNAGI’s predictions that nifedipine, an antihypertensive drug, may have anti-fbrotic efects on human tissues. UNAGI’s versatility extends to other diseases, including COVID, demonstrating adaptability and confrming its broader applicability in decoding complex cellular dynamics beyond idiopathic pulmonary fbrosis, amplifying its use in the quest for therapeutic solutions across diverse pathological landscapes.